Viewing Study NCT04340466


Ignite Creation Date: 2025-12-24 @ 4:33 PM
Ignite Modification Date: 2025-12-24 @ 4:33 PM
Study NCT ID: NCT04340466
Status: COMPLETED
Last Update Posted: 2025-12-03
First Post: 2020-04-07
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study
Sponsor: Centre Hospitalier Universitaire de Nīmes
Organization:

Study Overview

Official Title: French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management: the FRENCH CORONA Study
Status: COMPLETED
Status Verified Date: 2020-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FRENCH CORONA
Brief Summary: Since December 2019, a new agent, the SARS-Cov-2 coronavirus has been rapidly spreading from China to other countries causing an international outbreak of respiratory illnesses named COVID-19. In France, the first cases have been reported at the end of January with more than 60000 cases reported since then. A significant proportion (20-30%) of hospitalized COVID-19 patients will be admitted to intensive care unit. However, few data are available for this special population in France.

We conduct a large observational cohort of ICU suspected or proven COVID-19 patients that will enable to describe the initial management of COVID 19 patients admitted to ICU and to identify factors correlated to clinical outcome.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2020-A00797-32 OTHER ANSM View